Literature DB >> 28523369

[New strategies and technologies for ablation of atrial fibrillation : Where do we go?]

A Metzner1, J Riedl2, K-H Kuck2.   

Abstract

Catheter-based ablation is an established treatment option for patients with symptomatic atrial fibrillation (AF). Pulmonary vein isolation is the established cornerstone of all ablation strategies. However, the rate of electrical reconduction of previously isolated pulmonary veins is high and associated with recurrence of AF. Novel and innovative mapping and ablation systems are being developed or are under clinical evaluation aiming for higher durability of pulmonary vein isolation. Additional ablation strategies for patients with recurrence of AF despite persistent isolation of the pulmonary veins are under evaluation. These ablation strategies include ablation of complex fractionated atrial electrograms, linear lesions, rotors or drivers, fibrotic areas or ablation of extrapulmonary triggers. The true clinical benefit of these additional ablation strategies can only be assessed if the pulmonary veins are persistently isolated.

Entities:  

Keywords:  Ablation; Atrial fibrillation; Catheters; Cryoballoon; Pulmonary vein isolation

Mesh:

Year:  2017        PMID: 28523369     DOI: 10.1007/s00059-017-4573-2

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  22 in total

1.  Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis.

Authors:  Cees B de Vos; Ron Pisters; Robby Nieuwlaat; Martin H Prins; Robert G Tieleman; Robert-Jan S Coelen; Antonius C van den Heijkant; Maurits A Allessie; Harry J G M Crijns
Journal:  J Am Coll Cardiol       Date:  2010-02-23       Impact factor: 24.094

2.  Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up.

Authors:  Feifan Ouyang; Roland Tilz; Julian Chun; Boris Schmidt; Erik Wissner; Thomas Zerm; Kars Neven; Bulent Köktürk; Melanie Konstantinidou; Andreas Metzner; Alexander Fuernkranz; Karl-Heinz Kuck
Journal:  Circulation       Date:  2010-11-22       Impact factor: 29.690

3.  Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study.

Authors:  Petr Neuzil; Vivek Y Reddy; Josef Kautzner; Jan Petru; Dan Wichterle; Dipen Shah; Hendrik Lambert; Aude Yulzari; Erik Wissner; Karl-Heinz Kuck
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-03-20

4.  Ablation of rotor and focal sources reduces late recurrence of atrial fibrillation compared with trigger ablation alone: extended follow-up of the CONFIRM trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation).

Authors:  Sanjiv M Narayan; Tina Baykaner; Paul Clopton; Amir Schricker; Gautam G Lalani; David E Krummen; Kalyanam Shivkumar; John M Miller
Journal:  J Am Coll Cardiol       Date:  2014-03-13       Impact factor: 24.094

5.  Prevalence and distribution of focal triggers in persistent and long-standing persistent atrial fibrillation.

Authors:  Pasquale Santangeli; Erica S Zado; Mathew D Hutchinson; Michael P Riley; David Lin; David S Frankel; Gregory E Supple; Fermin C Garcia; Sanjay Dixit; David J Callans; Francis E Marchlinski
Journal:  Heart Rhythm       Date:  2015-10-23       Impact factor: 6.343

6.  Left atrial appendage: an underrecognized trigger site of atrial fibrillation.

Authors:  Luigi Di Biase; J David Burkhardt; Prasant Mohanty; Javier Sanchez; Sanghamitra Mohanty; Rodney Horton; G Joseph Gallinghouse; Shane M Bailey; Jason D Zagrodzky; Pasquale Santangeli; Steven Hao; Richard Hongo; Salwa Beheiry; Sakis Themistoclakis; Aldo Bonso; Antonio Rossillo; Andrea Corrado; Antonio Raviele; Amin Al-Ahmad; Paul Wang; Jennifer E Cummings; Robert A Schweikert; Gemma Pelargonio; Antonio Dello Russo; Michela Casella; Pietro Santarelli; William R Lewis; Andrea Natale
Journal:  Circulation       Date:  2010-07-06       Impact factor: 29.690

7.  Left Atrial Appendage Isolation in Patients With Longstanding Persistent AF Undergoing Catheter Ablation: BELIEF Trial.

Authors:  Luigi Di Biase; J David Burkhardt; Prasant Mohanty; Sanghamitra Mohanty; Javier E Sanchez; Chintan Trivedi; Mahmut Güneş; Yalçın Gökoğlan; Carola Gianni; Rodney P Horton; Sakis Themistoclakis; G Joseph Gallinghouse; Shane Bailey; Jason D Zagrodzky; Richard H Hongo; Salwa Beheiry; Pasquale Santangeli; Michela Casella; Antonio Dello Russo; Amin Al-Ahmad; Patrick Hranitzky; Dhanunjaya Lakkireddy; Claudio Tondo; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2016-11-01       Impact factor: 24.094

8.  Durability of Pulmonary Vein Isolation with Cryoballoon Ablation: Results from the Sustained PV Isolation with Arctic Front Advance (SUPIR) Study.

Authors:  Vivek Y Reddy; Lucie Sediva; Jan Petru; Jan Skoda; Milan Chovanec; Zita Chitovova; Paola Di Stefano; Ethel Rubin; Srinivas Dukkipati; Petr Neuzil
Journal:  J Cardiovasc Electrophysiol       Date:  2015-04-15

9.  Atrial fibrillation progression and management: a 5-year prospective follow-up study.

Authors:  Carlo Pappone; Andrea Radinovic; Francesco Manguso; Gabriele Vicedomini; Giuseppe Ciconte; Stefania Sacchi; Patrizio Mazzone; Gabriele Paglino; Simone Gulletta; Simone Sala; Vincenzo Santinelli
Journal:  Heart Rhythm       Date:  2008-08-17       Impact factor: 6.343

10.  Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation.

Authors:  Karl-Heinz Kuck; Josep Brugada; Alexander Fürnkranz; Andreas Metzner; Feifan Ouyang; K R Julian Chun; Arif Elvan; Thomas Arentz; Kurt Bestehorn; Stuart J Pocock; Jean-Paul Albenque; Claudio Tondo
Journal:  N Engl J Med       Date:  2016-04-04       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.